Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Brain Neoplasms"" wg kryterium: Temat


Tytuł:
Functional magnetic resonance imaging (fMRI) as adjunct for planning laser interstitial thermal therapy (LITT) near eloquent structures.
Autorzy:
Rifi Z; David Geffen School of Medicine, University of California, Los Angeles, USA.; Department of Neurosurgery, University of California, Los Angeles, USA.
Harary M; Department of Neurosurgery, University of California, Los Angeles, USA.
Walshaw PD; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA.
Frew AJ; Department of Neurosurgery, University of California, Los Angeles, USA.; Department of Radiology, University of California, Los Angeles, USA.
Everson RG; Department of Neurosurgery, University of California, Los Angeles, USA.
Fallah A; Department of Neurosurgery, University of California, Los Angeles, USA.
Salamon N; Department of Radiology, University of California, Los Angeles, USA.
Kim W; Department of Neurosurgery, University of California, Los Angeles, USA. .
Pokaż więcej
Źródło:
Acta neurochirurgica [Acta Neurochir (Wien)] 2024 Feb 05; Vol. 166 (1), pp. 66. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/surgery
Brain Neoplasms*/pathology
Laser Therapy*/methods
Humans ; Magnetic Resonance Imaging/methods ; Neurosurgical Procedures/methods ; Lasers
Czasopismo naukowe
Tytuł:
A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Autorzy:
Li Y; Department of Radiology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.
Lv X; Department of Radiology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.
Chen C; Institute of Advanced Research, Infervision Medical Technology Co., Ltd., Beijing, 100025, China.
Yu R; Institute of Advanced Research, Infervision Medical Technology Co., Ltd., Beijing, 100025, China.
Wang B; Department of Radiology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Wang D; Institute of Advanced Research, Infervision Medical Technology Co., Ltd., Beijing, 100025, China. .
Hou D; Department of Radiology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China. .
Pokaż więcej
Źródło:
European radiology experimental [Eur Radiol Exp] 2024 Jan 02; Vol. 8 (1), pp. 2. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/genetics
Deep Learning*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Humans ; Retrospective Studies ; Magnetic Resonance Imaging ; ErbB Receptors/genetics ; Mutation
Czasopismo naukowe
Tytuł:
GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas.
Autorzy:
He H; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Liang L; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Jiang S; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Liu Y; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Huang J; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Sun X; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Li Y; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China.
Jiang Y; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China. .; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China. .
Cong L; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China. .; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, China. .
Pokaż więcej
Źródło:
Cell death & disease [Cell Death Dis] 2024 Mar 11; Vol. 15 (3), pp. 205. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Glioma*/drug therapy
Glioma*/genetics
Glioma*/metabolism
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Humans ; Temozolomide/therapeutic use ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Neoplasm Recurrence, Local/drug therapy ; Epithelial Cells/metabolism ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Early Growth Response Protein 1/genetics ; Proto-Oncogene Proteins/pharmacology ; Chromosomal Proteins, Non-Histone
Czasopismo naukowe
Tytuł:
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Autorzy:
Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. .
Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey.
Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey.
Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey.
Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey.
Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey.
Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey.
Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey.
Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.
Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey.
Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey.
Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey.
Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey.
Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey.
Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Central Nervous System Neoplasms*/drug therapy
Humans ; Prognosis ; Retrospective Studies ; ErbB Receptors/genetics ; Treatment Outcome ; Protein Kinase Inhibitors/pharmacology
Czasopismo naukowe
Tytuł:
"sCT-Feasibility" - a feasibility study for deep learning-based MRI-only brain radiotherapy.
Autorzy:
Grigo J; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Szkitsak J; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Höfler D; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Putz F; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Bert C; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany. .; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Mar 08; Vol. 19 (1), pp. 33. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Deep Learning*
Radiotherapy, Intensity-Modulated*/methods
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
Humans ; Feasibility Studies ; Retrospective Studies ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy Dosage ; Magnetic Resonance Imaging/methods ; Brain/diagnostic imaging
Czasopismo naukowe
Tytuł:
Optimizing patient outcome in intracranial tumor surgery: a detailed prospective study of adverse events and mortality reduction strategies in neurosurgery.
Autorzy:
Lenga P; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. .; Medical Faculty of Heidelberg University, Heidelberg, Germany. .
Kleineidam H; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Medical Faculty of Heidelberg University, Heidelberg, Germany.
Unterberg A; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Medical Faculty of Heidelberg University, Heidelberg, Germany.
Dao Trong P; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Medical Faculty of Heidelberg University, Heidelberg, Germany.
Pokaż więcej
Źródło:
Acta neurochirurgica [Acta Neurochir (Wien)] 2024 Mar 08; Vol. 166 (1), pp. 126. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Neurosurgery*
Brain Neoplasms*/surgery
Brain Neoplasms*/complications
Glioma*/complications
Adult ; Humans ; Middle Aged ; Aged ; Prospective Studies ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Postoperative Hemorrhage
Czasopismo naukowe
Tytuł:
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
Autorzy:
Meng J; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Qian W; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Department of Clinical Laborator, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, 215300, Suzhou, Jiangsu, China.
Yang Z; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Gong L; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Xu D; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Huang H; NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, 214063, Wuxi, China.
Jiang X; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Pu Z; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Yin Y; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Zou J; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 317. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/metabolism
Humans ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; E2F7 Transcription Factor/metabolism ; Prognosis ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Tytuł:
Brain tumour microstructure is associated with post-surgical cognition.
Autorzy:
Aznarez-Sanado M; School of Education and Psychology, University of Navarra, 31009, Pamplona, Spain.
Romero-Garcia R; Department of Medical Physiology and Biophysics, Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla/CIBERSAM, ISCIII, 41013, Sevilla, Spain. .; Department of Psychiatry, University of Cambridge, Herchel Smith Bldg, Robinson Way, Cambridge, CB2 0SZ, UK. .
Li C; Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.; Department of Applied Mathematics and Theoretical Physics, The Centre for Mathematical Imaging in Healthcare, Cambridge, CB3 0WA, UK.; School of Medicine & School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK.
Morris RC; Academic Neurosurgery Division, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
Price SJ; Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
Manly T; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Santarius T; Academic Neurosurgery Division, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
Erez Y; Faculty of Engineering, Bar-Ilan University, 5290002, Ramat Gan, Israel.; The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel.
Hart MG; St George's, University of London and St George's University Hospitals NHS Foundation Trust, Institute of Molecular and Clinical Sciences, Neurosciences Research Centre, Cranmer Terrace, London, SW17 0RE, UK.
Suckling J; Department of Psychiatry, University of Cambridge, Herchel Smith Bldg, Robinson Way, Cambridge, CB2 0SZ, UK.; Cambridge and Peterborough NHS Foundation Trust, Cambridge, CB21 5EF, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5646. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/surgery
Brain Neoplasms*/pathology
Cognitive Dysfunction*
Female ; Humans ; Cognition ; Diffusion Magnetic Resonance Imaging/methods ; Cerebral Cortex/pathology ; Brain/pathology
Czasopismo naukowe
Tytuł:
Morphological differentiation of peritumoral brain zone microglia.
Autorzy:
Salas-Gallardo GA; Laboratorio de Células Neurales Troncales, CIACYT-Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, San Luis Potosí, México.; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Lorea-Hernández JJ; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Robles-Gómez ÁA; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Del Campo CC; Laboratorio de Células Neurales Troncales, CIACYT-Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, San Luis Potosí, México.
Peña-Ortega F; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0297576. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Glioblastoma*/pathology
Rats ; Animals ; Microglia/pathology ; Rats, Sprague-Dawley ; Neoplasm Recurrence, Local/pathology ; Brain/diagnostic imaging ; Brain/pathology ; Recurrence
Czasopismo naukowe
Tytuł:
Reproducibility of rCBV in glioblastomas using T2*-weighted perfusion MRI: an evaluation of sampling, normalization, and experience.
Autorzy:
Yüzkan S; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Mutlu S; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Karagülle M; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Şam Özdemir M; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Özgül H; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Arıkan MA; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Koçak B; University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Clinic of Radiology, İstanbul, Türkiye
Pokaż więcej
Źródło:
Diagnostic and interventional radiology (Ankara, Turkey) [Diagn Interv Radiol] 2024 Mar 06; Vol. 30 (2), pp. 124-134. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/diagnostic imaging
Glioblastoma*/blood supply
Glioblastoma*/pathology
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/blood supply
Brain Neoplasms*/pathology
Humans ; Cerebral Blood Volume ; Reproducibility of Results ; Retrospective Studies ; Contrast Media ; Magnetic Resonance Angiography/methods ; Perfusion ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł:
Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Autorzy:
Uehara R; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Obinata D; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Hashimoto S; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Nakahara K; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Uchida H; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Yoshizawa T; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Mochida J; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Yamaguchi K; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Sakaguchi M; Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Ozawa Y; Department of Neurological Surgery, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Mori F; Department of Neurological Surgery, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Miura K; Division of Hematology and Oncology, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Ishige T; Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Masuda S; Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Nakayama T; Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Takahashi S; Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2024 Mar 01; Vol. 103 (9), pp. e37371.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/diagnosis
Brain Neoplasms*/therapy
Brain Neoplasms*/drug therapy
Carcinoma*/drug therapy
Phthalazines*
Piperazines*
Male ; Humans ; Middle Aged ; Prostate-Specific Antigen ; Androgen Antagonists/therapeutic use ; Prostate/pathology ; Lymphatic Metastasis ; Neoplasm Recurrence, Local/drug therapy ; BRCA2 Protein
Czasopismo naukowe
Tytuł:
Deep learning-based metastasis detection in patients with lung cancer to enhance reproducibility and reduce workload in brain metastasis screening with MRI: a multi-center study.
Autorzy:
Park YW; Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Korea.
Park JE; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 43 Olympic-ro 88, Songpa-Gu, 05505, Seoul, Korea. .
Ahn SS; Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Korea. .
Han K; Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Korea.
Kim N; Dynapex, LLC, Seoul, Korea.
Oh JY; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 43 Olympic-ro 88, Songpa-Gu, 05505, Seoul, Korea.
Lee DH; Department of Radiology, Ajou University Medical Center, Suwon, Korea.
Won SY; Department of Radiology, Samsung Seoul Hospital, Seoul, Korea.
Shin I; Department of Radiology, The Catholic University of Korea, Seoul St. Mary's hospital, Seoul, Korea.
Kim HS; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 43 Olympic-ro 88, Songpa-Gu, 05505, Seoul, Korea.
Lee SK; Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Mar 01; Vol. 24 (1), pp. 32. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Deep Learning*
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/secondary
Humans ; Retrospective Studies ; Reproducibility of Results ; Workload ; Early Detection of Cancer ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł:
Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomes.
Autorzy:
Ressler HW; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: .
Cramer CK; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Isom S; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
McCormack M; Department of Medicine (Hematology & Oncology), Wake Forest School of Medicine, Winston-Salem, NC, USA.
Ruiz J; Department of Medicine (Hematology & Oncology), Wake Forest School of Medicine, Winston-Salem, NC, USA.
Xing F; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Li W; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Whitlow CT; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
White JJ; Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Laxton AW; Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Tatter SB; Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Chan MD; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Pokaż więcej
Źródło:
Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2024 Mar; Vol. 238, pp. 108191. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/pathology
Brain Neoplasms*/drug therapy
Brain Neoplasms*/pathology
Radiosurgery*/methods
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Humans ; Retrospective Studies ; Immunotherapy
Czasopismo naukowe
Tytuł:
Efficacy of hypofractionated Gamma Knife radiosurgery in treating surgical beds of metastatic brain tumors.
Autorzy:
Samanci Y; Koc University School of Medicine, Department of Neurosurgery, Istanbul, Turkey.
Ali Tepebasili M; Koc University School of Medicine, Department of Neurosurgery, Istanbul, Turkey.
Deniz Ardor G; Koc University Hospital, Department of Neurosurgery, Gamma Knife Center, Istanbul, Turkey.
Haluk Duzkalir A; Koc University Hospital, Department of Neurosurgery, Gamma Knife Center, Istanbul, Turkey.
Orbay Askeroglu M; Koc University Hospital, Department of Neurosurgery, Gamma Knife Center, Istanbul, Turkey.
Peker S; Koc University School of Medicine, Department of Neurosurgery, Istanbul, Turkey. Electronic address: .
Pokaż więcej
Źródło:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2024 Mar; Vol. 121, pp. 105-113. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*/methods
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/surgery
Humans ; Treatment Outcome ; Retrospective Studies ; Progression-Free Survival ; Follow-Up Studies
Czasopismo naukowe
Tytuł:
Stereotactic radiosurgery for brain metastases arising from gynecological malignancies: A retrospective treatment outcome analysis.
Autorzy:
Shopen Y; Department of Radiation Oncology, Sharett Institute of Oncology, Hebrew University Medical Center, Jerusalem, Israel.
Blumenfeld P; Department of Radiation Oncology, Sharett Institute of Oncology, Hebrew University Medical Center, Jerusalem, Israel. Electronic address: .
Grinshpun A; Department of Radiation Oncology, Sharett Institute of Oncology, Hebrew University Medical Center, Jerusalem, Israel.
Krakow A; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University, Jerusalem 91120, Israel.
Wygoda M; Department of Radiation Oncology, Sharett Institute of Oncology, Hebrew University Medical Center, Jerusalem, Israel.
Shoshan Y; Department of Neurosurgery, Hadassah Medical Center, Hebrew University Medical Center, Jerusalem, Israel.
Popovtzer A; Department of Radiation Oncology, Sharett Institute of Oncology, Hebrew University Medical Center, Jerusalem, Israel.
Falick Michaeli T; Department of Radiation Oncology, Sharett Institute of Oncology, Hebrew University Medical Center, Jerusalem, Israel; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University, Jerusalem 91120, Israel.
Pokaż więcej
Źródło:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2024 Mar; Vol. 121, pp. 89-96. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*
Genital Neoplasms, Female*/radiotherapy
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/surgery
Female ; Humans ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Deep learning segmentation of organs-at-risk with integration into clinical workflow for pediatric brain radiotherapy.
Autorzy:
Mekki L; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Acharya S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Ladra M; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Lee J; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Journal of applied clinical medical physics [J Appl Clin Med Phys] 2024 Mar; Vol. 25 (3), pp. e14310. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Deep Learning*
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
Humans ; Child ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Adult ; Workflow ; Image Processing, Computer-Assisted/methods ; Organs at Risk ; Radiotherapy Planning, Computer-Assisted/methods ; Brain/diagnostic imaging
Czasopismo naukowe
Tytuł:
Implementation and evaluation of a dynamic contrast-enhanced MR perfusion protocol for glioblastoma using a 0.35 T MRI-Linac system.
Autorzy:
Maziero D; Department of Radiation Medicine & Applied Sciences, UC San Diego Health, La Jolla, CA 92093, United States; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States. Electronic address: .
Azzam GA; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
de La Fuente M; Department of Neurology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
Stoyanova R; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
Ford JC; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
Mellon EA; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
Pokaż więcej
Źródło:
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) [Phys Med] 2024 Mar; Vol. 119, pp. 103316. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/diagnostic imaging
Glioblastoma*/radiotherapy
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
Humans ; Contrast Media ; Magnetic Resonance Imaging/methods ; Perfusion
Czasopismo naukowe
Tytuł:
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [ C]C-MET and Other Less-Commonly Used Radiotracers.
Autorzy:
Eisazadeh R; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria.
Shahbazi-Akbari M; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria; Research center for Nuclear Medicine, Department of Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mirshahvalad SA; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria; Research center for Nuclear Medicine, Department of Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran; Joint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital; University of Toronto, Toronto, Ontario, Canada.
Pirich C; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria.
Beheshti M; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria. Electronic address: .
Pokaż więcej
Źródło:
Seminars in nuclear medicine [Semin Nucl Med] 2024 Mar; Vol. 54 (2), pp. 293-301. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brain Neoplasms*/metabolism
Brain Neoplasms*/pathology
Glioma*
Humans ; Fluorodeoxyglucose F18 ; Artificial Intelligence ; Neoplasm Recurrence, Local/metabolism ; Positron-Emission Tomography/methods ; Amino Acids
Czasopismo naukowe
Tytuł:
Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.
Autorzy:
Virtanen PS; Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Ortiz KJ; Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Patel A; Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Blocher WA 3rd; Indiana University School of Medicine, Indianapolis, IN, USA.
Richardson AM; Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
Current oncology reports [Curr Oncol Rep] 2024 Mar; Vol. 26 (3), pp. 236-249. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Blood-Brain Barrier*/pathology
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/drug therapy
Humans ; Brain/pathology ; Mannitol/therapeutic use ; Drug Delivery Systems
Czasopismo naukowe
Tytuł:
Transcortical transcatheter ultrasound-assisted technique for deep-seated brain tumors. Technical note.
Autorzy:
García Pérez F; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain. .
Vargas López AJ; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Gomar Alba M; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Velasco Albendea FJ; Department of Pathology, Hospital Universitario Torrecárdenas, Almería, Spain.
Guil Ibáñez JJ; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Urreta Juárez G; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Castelló Ruiz MJ; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Narro Donate JM; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Masegosa González J; Department of Neurosurgery, Hospital Universitario Torrecárdenas, Calle Hermandad Donantes de Sangre S/N, 04009, Almería, Spain.
Pokaż więcej
Źródło:
Journal of ultrasound [J Ultrasound] 2024 Mar; Vol. 27 (1), pp. 191-197. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/surgery
Humans ; Ultrasonography
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies